Niche drugs become victims of their own success as off-label use leads to shortages

Saturday, November 30, 2019 - 12:27 in Health & Medicine

With IVIG in short supply, hospitals are left to make tough choices about who receives it. The expensive treatment may be a victim of its own widening use.

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net